Microbial metabolites diversity and their potential as molecular template for the discovery of new fluorescent and radiopharmaceutical probes

Abdel-Razek, 2020, Microbial natural products in drug discovery, Processes, 8, 1, 10.3390/pr8040470 Demain, 2009, Microbial drug discovery: 80 years of progress, J. Antibiot. (Tokyo), 62, 5, 10.1038/ja.2008.16 Sekurova, 2019, Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering, Microb. Biotechnol., 12, 828, 10.1111/1751-7915.13398 Pham, 2019, A review of the microbial production of bioactive natural products and biologics, Front. Microbiol., 10, 1, 10.3389/fmicb.2019.01404 Fischbach, 2009, Antibiotics from microbes: converging to kill, Curr. Opin. Microbiol., 12, 520, 10.1016/j.mib.2009.07.002 Atanasov, 2021, International natural product sciences taskforce, C.T. Supuran, natural products in drug discovery: advances and opportunities, Nat. Rev. Drug Discov., 20, 200, 10.1038/s41573-020-00114-z Lam, 2006, Discovery of novel metabolites from marine actinomycetes, Curr. Opin. Microbiol., 9, 245, 10.1016/j.mib.2006.03.004 Jakubczyk, 2020, Selected fungal natural products with antimicrobial properties, Molecules, 25, 1, 10.3390/molecules25040911 Rani, 2021, Microorganisms: a potential source of bioactive molecules for antioxidant applications, Molecules, 26, 1, 10.3390/molecules26041142 Carlson, 2010, Natural products as chemical probes, ACS Chem. Biol., 5, 639, 10.1021/cb100105c Huang, 2021, Recent progress in fluorescent probes for bacteria, Chem. Soc. Rev., 50, 7725, 10.1039/D0CS01340D Wongso, 2021, Design, synthesis, and biological evaluation of novel fluorescent probes targeting the 18-kDa translocator protein, ChemMedChem, 16, 1902, 10.1002/cmdc.202000984 Wongso, 2022, Natural product-based radiopharmaceuticals: focus on curcumin and its analogs, flavonoids, and marine peptides, J. Pharm. Anal., 12, 380, 10.1016/j.jpha.2021.07.006 Pellico, 2021, Radiolabelling of nanomaterials for medical imaging and therapy, Chem. Soc. Rev., 50, 3355, 10.1039/D0CS00384K Liu, 2010, Molecular optical imaging with radioactive probes, PLoS One, 5 Nagaya, 2017, Fluorescence-guided surgery, Front. Oncol., 7, 1, 10.3389/fonc.2017.00314 Arranz, 2015, Advances in optical imaging for pharmacological studies, Front. Pharmacol., 6, 189, 10.3389/fphar.2015.00189 Li, 2021, Recent progresses in NIR-I/II fluorescence imaging for surgical navigation, Front. Bioeng. Biotechnol., 9 Trapani, 2013, Targeting of the translocator protein 18 kDa (TSPO): a valuable approach for nuclear and optical imaging of activated microglia, Bioconjugate Chem., 24, 1415, 10.1021/bc300666f van Leeuwen, 2016, Hybrid surgical guidance based on the integration of radionuclear and optical technologies, Br. J. Radiol., 89, 10.1259/bjr.20150797 Yuen, 2022, Dual probes for positron emission tomography (PET) and fluorescence imaging (FI) of cancer, Pharmaceutics, 14, 1, 10.3390/pharmaceutics14030645 Chin, 2013, Optical imaging as an expansion of nuclear medicine: cerenkov-based luminescence vs fluorescence-based luminescence, Eur. J. Nucl. Med. Mol. Imag., 40, 1283, 10.1007/s00259-013-2408-9 Nahrendorf, 2010, Hybrid PET-optical imaging using targeted probes, Proc. Natl. Acad. Sci. USA, 107, 7910, 10.1073/pnas.0915163107 Singh, 2019, Editorial: microbial secondary metabolites: recent developments and technological challenges, Front. Microbiol., 10, 1, 10.3389/fmicb.2019.00914 Keswani, 2020, Antimicrobial secondary metabolites from agriculturally important bacteria as next-generation pesticides, Appl. Microbiol. Biotechnol., 104, 1013, 10.1007/s00253-019-10300-8 Gunatilaka, 2006, Natural products from plant-associated microorganisms: distribution, structural diversity, bioactivity, and implications of their occurrence, J. Nat. Prod., 69, 509, 10.1021/np058128n Wright, 2014, Something old, something new: revisiting natural products in antibiotic drug discovery, Can. J. Microbiol., 60, 147, 10.1139/cjm-2014-0063 Clardy, 2006, New antibiotics from bacterial natural products, Nat. Biotechnol., 24, 1541, 10.1038/nbt1266 Miethke, 2021, Towards the sustainable discovery and development of new antibiotics, Nat. Rev. Chem, 5, 726, 10.1038/s41570-021-00313-1 Rossiter, 2017, Natural products as platforms to overcome antibiotic resistance, Chem. Rev., 117, 12415, 10.1021/acs.chemrev.7b00283 Hutchings, 2019, Antibiotics: past, present and future, Curr. Opin. Microbiol., 51, 72, 10.1016/j.mib.2019.10.008 S-Cruz, 2018, Statistical-based database fingerprint: chemical space dependent representation of compound databases, J. Cheminf., 10, 1 Rubert, 2014, Metabolic fingerprinting based on high-resolution tandem mass spectrometry: a reliable tool for wine authentication?, Anal. Bioanal. Chem., 406, 6791, 10.1007/s00216-014-7864-y Duhrkop, 2015, Searching molecular structure databases with tandem mass spectra using CSI: FingerID, Proc. Natl. Acad. Sci. U.S.A., 112, 12580, 10.1073/pnas.1509788112 Fakih, 2019, Overview on antibacterial metabolites from terrestrial Aspergillus spp, Mycology, 10, 191, 10.1080/21501203.2019.1604576 Amend, 2019, Fungi in the marine environment: open questions and unsolved problems, mBio, 10 Shin, 2020, Natural products from marine fungi, Mar. Drugs, 18, 1, 10.3390/md18050230 Keller, 2019, Fungal secondary metabolism: regulation, function and drug discovery, Nat. Rev. Microbiol., 17, 167, 10.1038/s41579-018-0121-1 Lenzi, 2018, Medicinal fungi: a source of antiparasitic secondary metabolites, Appl. Microbiol. Biotechnol., 102, 5791, 10.1007/s00253-018-9048-8 Corinaldesi, 2017, Marine microbial-derived molecules and their potential use in cosmeceutical and cosmetic products, Mar. Drugs, 15, 1, 10.3390/md15040118 Gladfelter, 2019, Marine fungi, Curr. Biol. Mag., 29, 191, 10.1016/j.cub.2019.02.009 Debbab, 2010, Bioactive compounds from marine bacteria and fungi, Microb. Biotechnol., 3, 544, 10.1111/j.1751-7915.2010.00179.x Singh, 2019, Fungal-derived natural product: synthesis, function, and applications, 229 Boruta, 2018, Uncovering the repertoire of fungal secondary metabolites: from Fleming's laboratory to the International Space Station, Bioengineered, 9, 12, 10.1080/21655979.2017.1341022 Dayalan, 2011, Comparative study on production, purification of penicillin by Penicillium chrysogenum isolated from soil and citrus samples, Asian Pac. J. Trop. Biomed., 1, 15, 10.1016/S2221-1691(11)60061-0 Haseena, 2021, Enhanced antibacterial potential of amoxicillin against Helicobacter pylori mediated by lactobionic acid coated Zn-MOFs, Antibiotics (Basel), 10, 1 Malve, 2016, Exploring the ocean for new drug developments: marine pharmacology, J. Pharm. BioAllied Sci., 8, 83, 10.4103/0975-7406.171700 Chaudhry, 2019, Cephalosporins: a Focus on side chains and beta-lactam cross-reactivity, Pharmacy (Basel), 7, 1 Wu, 2018, The biological evaluation of fusidic acid and its hydrogenation derivative as antimicrobial and anti-inflammatory agents, Infect. Drug Resist., 11, 1945, 10.2147/IDR.S176390 Long, 2021, Bioactivities and structure-activity relationships of fusidic acid derivatives: a review, Front. Pharmacol., 12, 1, 10.3389/fphar.2021.759220 Wu, 2015, Lindgomycin, an unusual antibiotic polyketide from a marine fungus of the Lindgomycetaceae, Mar. Drugs, 13, 4617, 10.3390/md13084617 Stierle, 2017, The berkeleylactones, antibiotic macrolides from fungal coculture, J. Nat. Prod., 80, 1150, 10.1021/acs.jnatprod.7b00133 Kjer, 2009, Xanalteric acids I and II and related phenolic compounds from an endophytic Alternaria sp. isolated from the mangrove plant Sonneratia alba, J. Nat. Prod., 72, 2053, 10.1021/np900417g Ding, 2019, Bioprospecting of novel and bioactive metabolites from endophytic fungi isolated from rubber tree Ficus elastica leaves, J. Microbiol. Biotechnol., 29, 731, 10.4014/jmb.1901.01015 Wu, 2016, Engyodontochones, antibiotic polyketides from the marine fungus Engyodontium album strain LF069, Chem. Eur J., 22, 7452, 10.1002/chem.201600430 Wu, 2014, Two new antibiotic pyridones produced by a marine fungus, Trichoderma sp. strain MF106, Mar. Drugs, 12, 1208, 10.3390/md12031208 Niu, 2014, Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus, J. Nat. Prod., 77, 1021, 10.1021/np5000457 Guo, 2015, Penicyclones A-E, antibacterial polyketides from the deep-sea-derived fungus Penicillium sp. F23-2, J. Nat. Prod., 78, 2699, 10.1021/acs.jnatprod.5b00655 Subban, 2013, A novel antibacterial and antifungal phenolic compound from the endophytic fungus Pestalotiopsis mangiferae, Nat. Prod. Res., 27, 1445, 10.1080/14786419.2012.722091 Erbert, 2012, Antibacterial compound from the endophytic fungus Phomopsis longicolla isolated from the tropical red seaweed Bostrychia radicans, Bot. Mar., 55, 435, 10.1515/bot-2011-0023 Pinheiro, 2013, Antibacterial activity of alkaloids produced by endophytic fungus Aspergillus sp. EJC08 isolated from medical plant Bauhinia guianensis, Nat. Prod. Res., 27, 1633, 10.1080/14786419.2012.750316 Ola, 2013, Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis, J. Nat. Prod., 76, 2094, 10.1021/np400589h Macabeo, 2020, Tetrasubstituted α-pyrone derivatives from the endophytic fungus, Neurospora udagawae, Phytochem. Lett., 35, 147, 10.1016/j.phytol.2019.11.010 Qi, 2019, GKK1032C, a new alkaloid compound from the endophytic fungus Penicillium sp. CPCC 400817 with activity against methicillin-resistant S. aureus, J. Antibiot. (Tokyo), 72, 237, 10.1038/s41429-019-0144-5 Pandey, 2021, Secondary metabolites from bacteria and viruses, 19 Velmurugan, 2020, Marine bacteria Is the cell factory to produce bioactive pigments: a prospective pigment source in the ocean, Front. Sustain. Food Syst., 4, 1, 10.3389/fsufs.2020.589655 Seyedsayamdost, 2019, Toward a global picture of bacterial secondary metabolism, J. Ind. Microbiol. Biotechnol., 46, 301, 10.1007/s10295-019-02136-y Rahman, 2010, Novel anti-infective compounds from marine bacteria, Mar. Drugs, 8, 498, 10.3390/md8030498 Salwan, 2020, Molecular and biotechnological aspects of secondary metabolites in actinobacteria, Microbiol. Res., 231, 1, 10.1016/j.micres.2019.126374 Andryukov, 2019, The biotechnological potential of secondary metabolites from marine bacteria, J. Mar. Sci. Eng., 7, 1 Fouillaud, 2022, Microbial secondary metabolism and biotechnology, Microorganisms, 10, 1, 10.3390/microorganisms10010123 Luchian, 2021, Clindamycin as an alternative option in optimizing periodontal therapy, Antibiotics (Basel), 10, 1 Hasan, 2019, Bacteria-targeted clindamycin loaded polymeric nanoparticles: effect of surface charge on nanoparticle adhesion to MRSA, antibacterial activity, and wound healing, Pharmaceutics, 11, 1, 10.3390/pharmaceutics11050236 Chopra, 2001, Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance, Microbiol. Mol. Biol. Rev., 65, 232, 10.1128/MMBR.65.2.232-260.2001 Rusu, 2021, The development of third-generation tetracycline antibiotics and new perspectives, Pharmaceutics, 13, 1, 10.3390/pharmaceutics13122085 Jelic, 2016, From erythromycin to azithromycin and new potential ribosome-binding antimicrobials, Antibiotics (Basel), 5, 1 Wijesekara, 2017, Review on usage of vancomycin in livestock and humans: maintaining its efficacy, prevention of resistance and alternative therapy, Vet. Sci., 4, 1 Saeed, 2019, Incidence of vancomycin resistant phenotype of the methicillin resistant Staphylococcus aureus isolated from a tertiary care hospital in Lahore, Antibiotics (Basel), 9, 1 Chen, 2014, Update on new medicinal applications of gentamicin: evidence-based review, J. Formos. Med. Assoc., 113, 72, 10.1016/j.jfma.2013.10.002 Mrugala, 2021, A study on the structure, mechanism, and biochemistry of kanamycin B dioxygenase (KanJ)-an enzyme with a broad range of substrates, FEBS J., 288, 1366, 10.1111/febs.15462 Schneemann, 2010, Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea, J. Nat. Prod., 73, 1309, 10.1021/np100135b Brana, 2017, Branimycins B and C, antibiotics produced by the abyssal Actinobacterium Pseudonocardia carboxydivorans M-227, J. Nat. Prod., 80, 569, 10.1021/acs.jnatprod.6b01107 Xu, 2017, Ghanamycins A and B, two novel gamma-butyrolactones from marine-derived streptomyces ghanaensis TXC6-16, J. Antibiot. (Tokyo), 70, 733, 10.1038/ja.2017.37 Ma, 2017, Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents, Nat. Commun., 8, 1, 10.1038/s41467-017-00419-5 Beemelmanns, 2017, Glycosylated macrolactams from a termite-associated Amycolatopsis sp. M39, Org. Lett., 19, 1000, 10.1021/acs.orglett.6b03831 Shin, 2016, Actinomadurol, an antibacterial norditerpenoid from a rare actinomycete, Actinomadura sp. KC 191, J. Nat. Prod., 79, 1886, 10.1021/acs.jnatprod.6b00268 Ellis, 2014, Solwaric acids A and B, antibacterial aromatic acids from a marine Solwaraspora sp, Mar. Drugs, 12, 1013, 10.3390/md12021013 Huang, 2016, Anti-MRSA and anti-TB metabolites from marine-derived Verrucosispora sp. MS100047, Appl. Microbiol. Biotechnol., 100, 7437, 10.1007/s00253-016-7406-y Gong, 2018, Tetrocarcin Q, a new spirotetronate with a unique glycosyl group from a marine-derived Actinomycete Micromonospora carbonacea LS276, Mar. Drugs, 16, 1, 10.3390/md16020074 Iorio, 2018, Novel polyethers from screening Actinoallomurus spp, Antibiotics (Basel), 7, 1 Cruz, 2017, Allocyclinones, hyperchlorinated angucyclinones from Actinoallomurus, J. Antibiot. (Tokyo), 70, 73, 10.1038/ja.2016.62 Zhang, 2016, Micromonohalimanes A and B: antibacterial halimane-type diterpenoids from a marine Micromonospora species, J. Nat. Prod., 79, 2968, 10.1021/acs.jnatprod.6b00555 Ye, 2016, A new curvularin glycoside and its cytotoxic and antibacterial analogues from marine actinomycete Pseudonocardia sp. HS7, Nat. Prod. Res., 30, 1156, 10.1080/14786419.2015.1047775 Eltamany, 2014, New antibacterial xanthone from the marine sponge-derived Micrococcus sp. EG45, Bioorg. Med. Chem. Lett., 24, 4939, 10.1016/j.bmcl.2014.09.040 Refaat, 2022, In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications, J. Nanobiotechnol., 20, 1 Raymo, 2012, Photoactivatable fluorophores, ISRN Phys. Chem., 2012, 1, 10.5402/2012/619251 Valeur, 2012 van der Velde, 2016, A simple and versatile design concept for fluorophore derivatives with intramolecular photostabilization, Nat. Commun., 7, 1, 10.1038/ncomms10144 Hong, 2017, Near-infrared fluorophores for biomedical imaging, Nat. Biomed. Eng., 1, 1, 10.1038/s41551-016-0010 Martynov, 2016, Synthetic fluorophores for visualizing biomolecules in living systems, Acta Naturae, 8, 33, 10.32607/20758251-2016-8-4-33-46 Franke, 2019, BODIPY fluorophores for membrane potential imaging, J. Am. Chem. Soc., 141, 12824, 10.1021/jacs.9b05912 Debie, 2019, Emerging fluorescent molecular tracers to guide intra-operative surgical decision-making, Front. Pharmacol., 10, 1, 10.3389/fphar.2019.00510 Hilderbrand, 2010, Near-infrared fluorescence: application to in vivo molecular imaging, Curr. Opin. Chem. Biol., 14, 71, 10.1016/j.cbpa.2009.09.029 Reja, 2020, Near-infrared fluorescent probes: a next-generation tool for protein-labeling applications, Chem. Sci., 12, 3437, 10.1039/D0SC04792A Zhang, 2011, Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives, Expert Opin. Med. Diagn., 5, 241, 10.1517/17530059.2011.566858 Cutler, 2013, Radiometals for combined imaging and therapy, Chem. Rev., 113, 858, 10.1021/cr3003104 Wright, 2013, Designing the magic bullet? The advancement of immuno-PET into clinical use, J. Nucl. Med., 54, 1171, 10.2967/jnumed.113.126086 Skliarova, 2018, Innovative target for production of technetium-99m by biomedical cyclotron, Molecules, 24, 1, 10.3390/molecules24010025 Saptiama, 2016, Development of 99Mo/99mTc generator system for production of medical radionuclide 99mTc using a neutron-activated 99Mo and zirconium based material (ZBM) as its adsorbent, At. Indones., 42, 115, 10.17146/aij.2016.531 Boschi, 2019, A picture of modern Tc-99m radiopharmaceuticals: production, chemistry, and applications in molecular imaging, Appl. Sci., 9, 1, 10.3390/app9122526 Martini, 2018, Technetium complexes and radiopharmaceuticals with scorpionate ligands, Molecules, 23, 1, 10.3390/molecules23082039 Johnstone, 2017, Technetium: the first radioelement on the periodic table, J. Chem. Educ., 94, 320, 10.1021/acs.jchemed.6b00343 Shahzad, 2021, Recent advances in the synthesis of (99mTechnetium) based radio-pharmaceuticals, Rev. Inorg. Chem., 41, 151, 10.1515/revic-2020-0021 Kniess, 2017, Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection, Dalton Trans., 46, 14435, 10.1039/C7DT01735A Lepareur, 2022, Cold kit labeling: the future of 68Ga radiopharmaceuticals?, Front. Med., 9, 1, 10.3389/fmed.2022.812050 Velikyan, 2015, 68Ga-Based radiopharmaceuticals: production and application relationship, Molecules, 20, 12913, 10.3390/molecules200712913 Suthiram, 2021, Towards facile radiolabeling and preparation of gallium-68-/bismuth-213-DOTA-[Thi8, Met(O2)11]-substance P for future clinical application: first experiences, Pharmaceutics, 13, 1, 10.3390/pharmaceutics13091326 Dash, 2015, Production of 177Lu for targeted radionuclide therapy: available options, Nucl. Med. Mol. Imaging, 49, 85, 10.1007/s13139-014-0315-z Mikolajczak, 2019, Radiometals for imaging and theranostics, current production, and future perspectives, J. Label. Compd. Radiopharm., 62, 615, 10.1002/jlcr.3770 Banerjee, 2015, Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications, Chem. Rev., 115, 2934, 10.1021/cr500171e Ferris, 2021, Use of radioiodine in nuclear medicine-A brief overview, J. Label. Compd. Radiopharm., 64, 92, 10.1002/jlcr.3891 Kumar, 2021, A novel reagent for radioiodine labeling of new chemical entities (NCEs) and biomolecules, Molecules, 26, 1, 10.3390/molecules26144344 Kumar, 2021, Radiochemistry, production processes, labeling methods, and immunoPET imaging pharmaceuticals of iodine-124, Molecules, 26, 1, 10.3390/molecules26020414 Braghirolli, 2014, Production of iodine-124 and its applications in nuclear medicine, Appl. Radiat. Isot., 90, 138, 10.1016/j.apradiso.2014.03.026 Robbins, 2005, The evolving role of 131I for the treatment of differentiated thyroid carcinoma, J. Nucl. Med., 46, 28S Dubost, 2020, Recent advances in synthetic methods for radioiodination, J. Org. Chem., 85, 8300, 10.1021/acs.joc.0c00644 Kusumaningrum, 2021, Pharmacological activities and potential use of bovine colostrum for peptide-based radiopharmaceuticals: a review, Pharmacia, 68, 471, 10.3897/pharmacia.68.e65537 Jauregui-Osoro, 2021, Production of copper-64 using a hospital cyclotron: targetry, purification and quality analysis, Nucl. Med. Commun., 42, 1024, 10.1097/MNM.0000000000001422 Tiba, 2021, Production of the isotope copper-64 by using natural nickel target with proton energy 17 MeV and beam current 10 μA at cyclotron, J. Phys. Conf., 2103 Xie, 2017, Establishing reliable Cu-64 production process: from target plating to molecular specific tumor micro-PET imaging, Molecules, 22, 1, 10.3390/molecules22040641 Tamura, 2013, 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer, J. Nucl. Med., 54, 1869, 10.2967/jnumed.112.118612 Pfeifer, 2012, Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study, J. Nucl. Med., 53, 1207, 10.2967/jnumed.111.101469 Maheshwari, 2012, Measurement of the rate of copper(II) exchange for 64Cu complexes of bifunctional chelators, Inorg. Chim. Acta., 393, 318, 10.1016/j.ica.2012.07.012 Nagle, 2021, Imaging tumor-infiltrating lymphocytes in brain tumors with [64Cu]Cu-NOTA-anti-CD8 PET, Clin. Cancer Res., 27, 1958, 10.1158/1078-0432.CCR-20-3243 Poulie, 2021, Evaluation of [64Cu]Cu-NOTA-PEG7-H-tz for pretargeted imaging in LS174T xenografts-comparison to [111In]In-DOTA-PEG11-BisPy-Tz, Molecules, 26, 1, 10.3390/molecules26030544 DeJesus, 2012, Synthesis of [64Cu]Cu-NOTA-Bn-GE11 for PET imaging of EGFR-rich tumors, Curr. Rad., 5, 15, 10.2174/1874471011205010015 Alves, 2017, Production of copper-64 and gallium-68 with a medical cyclotron using liquid targets, Mod. Phys. Lett. A, 32, 10.1142/S0217732317400132 2016 Webster, 2014, The production of radionuclides for nuclear medicine from a compact, low-energy accelerator system, Nucl. Med. Biol., 41, e7, 10.1016/j.nucmedbio.2013.11.007 Medina, 2015, 64Cu-CTS: a promising radiopharmaceutical for the identification of low-grade cardiac hypoxia by PET, J. Nucl. Med., 56, 921, 10.2967/jnumed.114.148353 Handley, 2014, Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM, J. Nucl. Med., 55, 488, 10.2967/jnumed.113.129015 Handley, 2013, Demonstration of the retention of 64Cu-ATSM in cardiac myocytes using a novel incubation chamber for screening hypoxia-dependent radiotracers, Nucl. Med. Commun., 34, 1015, 10.1097/MNM.0b013e328363f25e Larenkov, 2021, Separation of 44Sc from 44Ti in the context of a generator system for radiopharmaceutical purposes with the example of [44Sc]Sc-PSMA-617 and [44Sc]Sc-PSMA-I&T synthesis, Molecules, 26, 1, 10.3390/molecules26216371 Mikolajczak, 2021, Production of scandium radionuclides for theranostic applications: towards standardization of quality requirements, EJNMMI Radiopharm. Chem., 6, 1, 10.1186/s41181-021-00131-2 Lowis, 2021, Improved Sc-44 production in a siphon-style liquid target on a medical cyclotron, Appl. Radiat. Isot., 172, 10.1016/j.apradiso.2021.109675 Sinnes, 2020, 68Ga, 44Sc and 177Lu-labeled AAZTA(5)-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues, EJNMMI Radiopharm. Chem., 5, 1, 10.1186/s41181-020-00107-8 Singh, 2017, First-in-human PET/CT imaging of metastatic neuroendocrine neoplasms with cyclotron-produced 44Sc-DOTATOC: a proof-of-concept study, Cancer Biother. Radiopharm., 32, 124 Pruszynski, 2010, Post-elution processing of 44Ti/44Sc generator-derived 44Sc for clinical application, Appl. Radiat. Isot., 68, 1636, 10.1016/j.apradiso.2010.04.003 Loveless, 2021, Cyclotron production and separation of scandium radionuclides from natural titanium metal and titanium dioxide targets, J. Nucl. Med., 62, 131, 10.2967/jnumed.120.242941 Sitarz, 2018, Production of Sc medical radioisotopes with proton and deuteron beams, Appl. Radiat. Isot., 142, 104, 10.1016/j.apradiso.2018.09.025 Eppard, 2017, Clinical translation and first in-human use of [44Sc]Sc-PSMA-617 for PET imaging of metastasized castrate-resistant prostate cancer, Theranostics, 7, 4359, 10.7150/thno.20586 Bhatt, 2018, Recent advances in zirconium-89 chelator development, Molecules, 23, 1, 10.3390/molecules23030638 Zhang, 2011, PET tracers based on zirconium-89, Curr. Rad., 4, 131, 10.2174/1874471011104020131 Dilworth, 2018, The chemistry of PET imaging with zirconium-89, Chem. Soc. Rev., 47, 2554, 10.1039/C7CS00014F Deri, 2013, PET imaging with 89Zr: from radiochemistry to the clinic, Nucl. Med. Biol., 40, 3, 10.1016/j.nucmedbio.2012.08.004 Wooten, 2013, Routine production of 89Zr using an automated module, Appl. Sci., 3, 593, 10.3390/app3030593 Holland, 2009, Standardized methods for the production of high specific-activity zirconium-89, Nucl. Med. Biol., 36, 729, 10.1016/j.nucmedbio.2009.05.007 van de Watering, 2014, Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients, BioMed Res. Int., 2014, 1, 10.1155/2014/203601 Zeglis, 2015, The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies, JoVE, 96, 1 Summer, 2018, Cyclic versus noncyclic chelating scaffold for 89Zr-Labeled ZEGFR: 2377 affibody bioconjugates targeting epidermal growth factor receptor overexpression, Mol. Pharm., 15, 175, 10.1021/acs.molpharmaceut.7b00787 Perk, 2010, A new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging, Eur. J. Nucl. Med. Mol. Imag., 37, 250, 10.1007/s00259-009-1263-1 van der Born, 2017, Fluorine-18 labelled building blocks for PET tracer synthesis, Chem. Soc. Rev., 46, 4709, 10.1039/C6CS00492J Brust, 2014, Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography, Neurosci. Bull., 30, 777, 10.1007/s12264-014-1460-6 Shah, 2007, The role of fluorine in medicinal chemistry, J. Enzym. Inhib. Med. Chem., 22, 527, 10.1080/14756360701425014 Alauddin, 2012, Positron emission tomography (PET) imaging with 18F-based radiotracers, Am. J. Nucl. Med. Mol. Imaging, 2, 55 Bortolozzi, 2019, Evaluating the effects of fluorine on biological properties and metabolic stability of some antitubulin 3-substituted 7-phenyl-pyrroloquinolinones, Eur. J. Med. Chem., 178, 297, 10.1016/j.ejmech.2019.05.092 Jacobson, 2015, Fluorine-18 radiochemistry, labeling strategies and synthetic routes, Bioconjugate Chem., 26, 1, 10.1021/bc500475e Gillis, 2015, Applications of fluorine in medicinal chemistry, J. Med. Chem., 58, 8315, 10.1021/acs.jmedchem.5b00258 Meng, 2020, Development of a naphthlimide-based fluorescent probe for imaging monoamine oxidase A in living cells and zebrafish, Dyes Pigments, 176, 10.1016/j.dyepig.2020.108208 Li, 2020, Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications, J. Am. Chem. Soc., 142, 14789, 10.1021/jacs.0c07022 Kocaoglu, 2016, Progress and prospects for small-molecule probes of bacterial imaging, Nat. Chem. Biol., 12, 472, 10.1038/nchembio.2109 Wang, 2018, Antibiotics-based fluorescent probes for selective labeling of Gram-negative and Gram-positive bacteria in living microbiotas, Sci. China Chem., 61, 792, 10.1007/s11426-018-9236-5 Stone, 2020, Visualization of bacterial resistance using fluorescent antibiotic probes, JoVE, 1 Miao, 2020, Fluorescent antibiotics for real-time tracking of pathogenic bacteria, J. Pharm. Anal., 10, 444, 10.1016/j.jpha.2020.09.003 McDermott, 2003, Antimicrobials: modes of action and mechanisms of resistance, Int. J. Toxicol., 22, 135, 10.1080/10915810305089 Kapoor, 2017, Action and resistance mechanisms of antibiotics: a guide for clinicians, J. Anaesthesiol. Clin. Pharmacol., 33, 300, 10.4103/joacp.JOACP_349_15 Frere, 2014, Penicillin-binding proteins: evergreen drug targets, Curr. Opin. Pharmacol., 18, 112, 10.1016/j.coph.2014.09.012 Zhao, 1999, Bocillin FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins, Antimicrob. Agents Chemother., 43, 1124, 10.1128/AAC.43.5.1124 Marshall, 2020, Enzyme-targeted fluorescent small-molecule probes for bacterial imaging, Curr. Opin. Chem. Biol., 57, 155, 10.1016/j.cbpa.2020.05.012 van Oosten, 2013, Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labelled vancomycin, Nat. Commun., 4, 1, 10.1038/ncomms3584 Escobedoa, 2012, Live cell imaging of a fluorescent gentamicin conjugate, Nat. Prod. Commun., 7, 317 Azad, 2020, Fluorescent aminoglycoside antibiotics and methods for accurately monitoring uptake by bacteria, ACS Infect. Dis., 6, 1008, 10.1021/acsinfecdis.9b00421 Gee, 2001, Fluorescent bocillins: synthesis and application in the detection of penicillin-binding proteins, Electrophoresis, 22, 960, 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9 Kocaoglu, 2012, Selective penicillin-binding protein imaging probes reveal substructure in bacterial cell division, ACS Chem. Biol., 7, 1746, 10.1021/cb300329r Woiwode, 2016, Preparation of fluorescent labeled gentamicin as biological tracer and its characterization by liquid chromatography and high resolution mass spectrometry, J. Pharm. Biomed. Anal., 121, 307, 10.1016/j.jpba.2015.12.053 Sharifzadeh, 2017, Novel electrophilic scaffold for imaging of essential penicillin-binding proteins in Streptococcus pneumoniae, ACS Chem. Biol., 12, 2849, 10.1021/acschembio.7b00614 Xing, 2011, Multifunctional divalent vancomycin: the fluorescent imaging and photodynamic antimicrobial properties for drug resistant bacteria, Chem. Commun., 47, 1601, 10.1039/C0CC04434B Wrobel, 2019, Trimethoprim: an old antibacterial drug as a template to search for new targets. Synthesis, biological activity and molecular modeling study of novel trimethoprim analogs, Molecules, 25, 1, 10.3390/molecules25010116 Phetsang, 2016, Fluorescent trimethoprim conjugate probes to assess drug accumulation in wild type and mutant Escherichia coli, ACS Infect. Dis., 2, 688, 10.1021/acsinfecdis.6b00080 Reessing, 2020, A facile and reproducible synthesis of near-infrared fluorescent conjugates with small targeting molecules for microbial infection imaging, ACS Omega, 5, 22071, 10.1021/acsomega.0c02094 Fu, 2018, Small-molecule fluorescent probes and their design, RSC Adv., 8, 29051, 10.1039/C8RA02297F Zheng, 2022, NIR-I dye-based probe: a new window for bimodal tumor theranostics, Front. Chem., 10, 10.3389/fchem.2022.859948 Chen, 2021, Recent advances in second near-infrared region (NIR-II) fluorophores and biomedical applications, Front. Chem., 9, 10.3389/fchem.2021.750404 Zhang, 2021, Design and application of receptor-targeted fluorescent probes based on small molecular fluorescent dyes, Bioconjugate Chem., 32, 4, 10.1021/acs.bioconjchem.0c00606 Shahzadi, 2019, 99mTc-amoxicillin: a novel radiopharmaceutical for infection imaging, Arab. J. Chem., 12, 2533, 10.1016/j.arabjc.2015.04.003 Auletta, 2016, Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review, Clin. Transl. Imaging, 4, 229, 10.1007/s40336-016-0185-8 Vito, 2016, A 99mTc-labelled tetrazine for bioorthogonal chemistry. Synthesis and biodistribution studies with small molecule trans-cyclooctene derivatives, PLoS One, 11, 10.1371/journal.pone.0167425 Jalilian, 2008, Evaluation of [201TI](III) vancomycin in normal rats, Nucl. Med. Rev. Cent. E Eur., 11, 1 Roohi, 2005, Synthesis and biodistribution of 99mTc-vancomycin in a model of bacterial infection, Radiochim. Acta, 93, 415, 10.1524/ract.2005.93.7.415 Ozdemir, 2015, Evaluation of 99mTc-amoxicillin sodium as an infection imaging agent in bacterially infected and sterile inflamed rats, J. Radioanal. Nucl. Chem., 308, 995, 10.1007/s10967-015-4516-4 Hina, 2014, Preparation, biodistribution, and scintigraphic evaluation of 99mTc-clindamycin: an infection imaging agent, Appl. Biochem. Biotechnol., 174, 1420, 10.1007/s12010-014-1075-z Ghaney, 2013, Synthesis of 99mTc-erythromycin complex as a model for infection sites imaging, Radiochemistry, 55, 418, 10.1134/S1066362213040139 Roohi, 2006, Synthesis, quality control and biodistribution of 99mTc-kanamycin, J. Radioanal. Nucl. Chem., 267, 561, 10.1007/s10967-006-0087-8 Akbar, 2017, Radiolabeling, quality control, and biological characterization of 177Lu-labeled kanamycin, Chem. Biol. Drug Des., 90, 425, 10.1111/cbdd.12960 Masson, 1983, Synthesis of a 1251-radiolabeled for penicillin-binding penicillin proteins studies, Anal. Biochem., 128, 164, 10.1016/0003-2697(83)90357-3 Preston, 1990, Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins, Antimicrob. Agents Chemother., 34, 718, 10.1128/AAC.34.5.718 Widyasari, 2016, Preparation of 99mTc-kanamycin using a direct labeling method, At. Indones., 41, 131, 10.17146/aij.2015.413 do Carmo, 2020, Production of radiometals in liquid targets, EJNMMI Radiopharm. Chem., 5, 1, 10.1186/s41181-019-0088-x Giglio, 2019, 99mTc labelling strategies for the development of potential nitroimidazolic hypoxia imaging agents, INORGA, 7, 1, 10.3390/inorganics7110128 Chaturvedi, 2016, Small molecule radiopharmaceuticals-a review of current approaches, Front. Med., 3, 1, 10.3389/fmed.2016.00005 Price, 2014, Matching chelators to radiometals for radiopharmaceuticals, Chem. Soc. Rev., 43, 260, 10.1039/C3CS60304K Richter, 2014, 18F-labeled peptides: the future is bright, Molecules, 19, 20536, 10.3390/molecules191220536 Liu, 2013, Microfluidics for synthesis of peptide-based PET tracers, BioMed Res. Int., 2013, 10.1155/2013/839683 Navarro, 2019, Prosthetic groups for radioiodination and astatination of peptides and proteins: a comparative study of five potential bioorthogonal labeling strategies, Bioorg. Med. Chem., 27, 167, 10.1016/j.bmc.2018.11.034